Lamitor DT 25 Tablet contains Lamotrigine 25mg, an anticonvulsant medication primarily indicated for the treatment of epilepsy and bipolar disorder. Lamotrigine acts by stabilizing neuronal membranes through inhibition of voltage-sensitive sodium channels, thereby reducing the release of excitatory neurotransmitters such as glutamate. This mechanism helps in controlling seizures and mood episodes. Lamitor DT 25 is specifically formulated as a dispersible tablet, allowing for rapid disintegration in the oral cavity, facilitating ease of administration, particularly in patients with swallowing difficulties. It is commonly prescribed as adjunctive therapy for partial seizures, generalized seizures including tonic-clonic and absence seizures, and for maintenance treatment of bipolar disorder to delay mood episode recurrence. Dosage must be individualized based on patient response and tolerability, with gradual titration recommended to minimize the risk of serious skin reactions such as Stevens-Johnson syndrome. Common adverse effects may include dizziness, headache, blurred vision, and nausea. Lamitor DT 25 should be used cautiously in patients with hepatic impairment and requires regular monitoring. It is contraindicated in individuals with known hypersensitivity to Lamotrigine or any tablet components. Patients are advised to adhere strictly to prescribed dosing and report any rash or adverse symptoms promptly to healthcare providers.